Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Dmytruk Mark E.. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Dmytruk Mark E. har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
See remarks 46.226
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Dmytruk Mark E.. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Dmytruk Mark E. som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-05-22 2025-05-21 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -706 46.226 -1,50 7,58 -5.355 350.624
2025-05-22 2025-05-20 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 572 46.932 1,23
2025-05-22 2025-05-20 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 453 46.360 0,99
2025-05-22 2025-05-20 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 454 45.907 1,00
2025-04-23 2025-04-21 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -1.244 45.453 -2,66 7,28 -9.060 331.034
2025-04-23 2025-04-17 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 8 46.697 0,02
2025-04-23 2025-04-17 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.061 46.689 2,33
2025-04-23 2025-04-17 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 572 45.628 1,27
2025-04-23 2025-04-17 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 453 45.056 1,02
2025-04-23 2025-04-17 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 454 44.603 1,03
2025-03-17 2025-03-13 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
C - Conversion 9.497 44.149 27,41
2025-03-06 2025-03-04 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -790 34.652 -2,23 7,72 -6.103 267.687
2025-03-06 2025-03-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 572 35.442 1,64
2025-03-06 2025-03-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 453 34.870 1,32
2025-03-06 2025-03-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 454 34.417 1,34
2025-02-06 2025-02-04 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -740 33.963 -2,13 13,44 -9.948 456.565
2025-02-06 2025-02-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 8 34.703 0,02
2025-02-06 2025-02-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 572 34.695 1,68
2025-02-06 2025-02-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 453 34.123 1,35
2025-02-06 2025-02-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 454 33.670 1,37
2025-01-08 2025-01-06 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -645 33.216 -1,90 11,72 -7.558 389.225
2025-01-08 2025-01-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 572 33.861 1,72
2025-01-08 2025-01-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 453 33.289 1,38
2025-01-08 2025-01-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 450 32.836 1,39
2024-12-05 2024-12-04 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -741 32.386 -2,24 9,64 -7.146 312.331
2024-12-05 2024-12-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 8 33.127 0,02
2024-12-05 2024-12-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 572 33.119 1,76
2024-12-05 2024-12-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 453 32.547 1,41
2024-12-05 2024-12-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 484 32.094 1,53
2024-11-06 2024-11-04 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -1.322 31.610 -4,01 7,58 -10.015 239.477
2024-11-06 2024-11-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 36 32.932 0,11
2024-11-06 2024-11-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 572 32.896 1,77
2024-11-06 2024-11-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 453 32.324 1,42
2024-11-06 2024-11-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.634 31.871 5,40
2024-10-08 2024-10-04 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -1.217 30.237 -3,87 8,35 -10.163 252.509
2024-10-08 2024-10-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 46 31.454 0,15
2024-10-08 2024-10-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 572 31.408 1,85
2024-10-08 2024-10-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 453 30.836 1,49
2024-10-08 2024-10-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.634 30.383 5,68
2024-09-16 2024-09-12 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -1.148 28.749 -3,84 6,17 -7.085 177.439
2024-09-16 2024-09-11 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 34 29.897 0,11
2024-09-16 2024-09-11 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 572 29.863 1,95
2024-09-16 2024-09-11 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 453 29.291 1,57
2024-09-16 2024-09-11 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.634 28.838 6,01
2024-08-06 2024-08-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -63.567 1.088.186 -5,52 0,29 -18.244 312.309
2024-08-06 2024-08-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.636 1.151.753 0,14
2024-08-06 2024-08-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 22.917 1.150.117 2,03
2024-08-06 2024-08-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 1.127.200 1,63
2024-08-06 2024-08-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.449 1.109.075 6,27
2024-07-05 2024-07-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -49.162 1.043.626 -4,50 0,33 -16.027 340.222
2024-07-05 2024-07-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.635 1.092.788 0,15
2024-07-05 2024-07-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 22.916 1.091.153 2,15
2024-07-05 2024-07-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 1.068.237 1,73
2024-07-05 2024-07-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.450 1.050.112 6,65
2024-06-05 2024-06-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -48.866 984.662 -4,73 0,55 -26.827 540.579
2024-06-05 2024-05-31 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.638 1.033.528 0,16
2024-06-05 2024-05-31 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 22.917 1.031.890 2,27
2024-06-05 2024-05-31 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 1.008.973 1,83
2024-06-05 2024-05-31 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.448 990.848 7,07
2024-05-06 2024-05-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -47.806 925.400 -4,91 0,84 -40.396 781.963
2024-05-06 2024-05-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.635 973.206 0,17
2024-05-06 2024-05-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 22.917 971.571 2,42
2024-05-06 2024-05-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 948.654 1,95
2024-05-06 2024-05-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.450 930.529 7,57
2024-04-04 2024-04-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -51.169 865.079 -5,58 1,05 -53.727 908.333
2024-04-04 2024-04-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.634 916.248 0,18
2024-04-04 2024-04-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 22.916 914.614 2,57
2024-04-04 2024-04-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 891.698 2,07
2024-04-04 2024-04-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.448 873.573 8,10
2024-03-06 2024-03-04 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -38.826 808.125 -4,58 1,26 -48.765 1.015.005
2024-03-06 2024-03-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.638 846.951 0,19
2024-03-06 2024-03-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 845.313 2,19
2024-03-06 2024-03-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.451 827.188 8,59
2024-02-06 2024-02-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -39.569 761.737 -4,94 1,21 -47.799 920.178
2024-02-06 2024-02-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.635 801.306 0,20
2024-02-06 2024-02-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 799.671 2,32
2024-02-06 2024-02-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.448 781.546 9,14
2024-01-05 2024-01-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -45.794 716.098 -6,01 1,54 -70.523 1.102.791
2024-01-05 2024-01-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.639 761.892 0,22
2024-01-05 2024-01-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 760.253 2,44
2024-01-05 2024-01-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.284 742.128 9,65
2023-12-06 2023-12-04 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -42.402 676.844 -5,90 1,39 -58.812 938.783
2023-12-06 2023-12-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.634 719.246 0,23
2023-12-06 2023-12-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 717.612 2,59
2023-12-06 2023-12-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.281 699.487 10,29
2023-11-06 2023-11-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -37.229 634.206 -5,54 1,50 -55.918 952.577
2023-11-06 2023-11-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.635 671.435 0,24
2023-11-06 2023-11-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 669.800 2,78
2023-11-06 2023-11-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.282 651.675 11,13
2023-10-04 2023-10-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -42.237 586.393 -6,72 1,76 -74.464 1.033.811
2023-10-04 2023-10-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.637 628.630 0,26
2023-10-04 2023-10-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 626.993 2,98
2023-10-04 2023-10-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.283 608.868 12,01
2023-09-06 2023-09-05 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -41.417 543.585 -7,08 2,24 -92.567 1.214.912
2023-09-06 2023-09-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.636 585.002 0,28
2023-09-06 2023-09-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 583.366 3,21
2023-09-06 2023-09-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.282 565.241 13,06
2023-08-04 2023-08-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -46.519 499.959 -8,51 2,07 -96.248 1.034.415
2023-08-04 2023-08-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.638 546.478 0,30
2023-08-04 2023-08-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 544.840 3,44
2023-08-04 2023-08-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.283 526.715 14,15
2023-07-06 2023-07-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -40.637 461.432 -8,09 1,80 -73.228 831.500
2023-07-06 2023-07-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.634 502.069 0,33
2023-07-06 2023-07-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 500.435 3,76
2023-07-06 2023-07-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.282 482.310 15,65
2023-06-06 2023-06-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -40.511 417.028 -8,85 1,56 -63.400 652.649
2023-06-06 2023-06-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.635 457.539 0,36
2023-06-06 2023-06-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 455.904 4,14
2023-06-06 2023-06-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.284 437.779 17,53
2023-05-24 2023-05-22 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale X -250.000 372.495 -40,16 1,50 -375.000 558.742
2023-05-04 2023-05-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -38.802 622.495 -5,87 1,15 -44.506 714.002
2023-05-04 2023-05-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.637 661.297 0,25
2023-05-04 2023-05-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 659.660 2,83
2023-05-04 2023-05-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.281 641.535 11,33
2023-04-11 2023-04-10 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -740 576.254 -0,13 1,33 -986 768.147
2023-04-11 2023-04-06 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.636 576.994 0,28
2023-04-05 2023-04-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -38.787 575.358 -6,32 1,27 -49.221 730.129
2023-04-05 2023-03-31 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 18.125 614.145 3,04
2023-04-05 2023-03-31 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.284 596.020 12,30
2023-03-16 2023-03-15 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -29.762 530.736 -5,31 1,31 -39.107 697.387
2023-03-16 2023-03-14 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.281 560.498 13,18
2023-03-03 2023-03-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.635 495.217 0,33
2023-02-03 2023-02-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -27.889 493.582 -5,35 2,15 -59.933 1.060.708
2023-02-03 2023-02-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.638 521.471 0,32
2023-02-03 2023-02-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 65.284 519.833 14,36
2023-01-06 2023-01-04 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -34.588 454.549 -7,07 1,56 -53.819 707.278
2023-01-06 2023-01-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.635 489.137 0,34
2023-01-06 2023-01-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 66.947 487.502 15,92
2022-12-05 2022-12-02 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -30.102 420.555 -6,68 1,94 -58.488 817.138
2022-12-05 2022-12-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.634 450.657 0,36
2022-12-05 2022-12-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 64.949 449.023 16,91
2022-11-07 2022-11-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -30.604 384.074 -7,38 2,64 -80.948 1.015.876
2022-11-07 2022-11-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 1.638 414.678 0,40
2022-11-07 2022-11-01 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 64.951 413.040 18,66
2022-11-07 2022-10-06 4/A DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -279.255 348.089 -44,51 3,25 -907.579 1.131.289
2022-11-07 2022-10-05 4/A DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 618.242 627.344 6.792,38
2022-10-07 2022-10-06 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -279.255 348.089 -44,51 3,25 -907.579 1.131.289
2022-10-07 2022-10-05 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 618.242 627.344 6.792,38
2022-10-04 2022-10-03 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
S - Sale -7.259 9.102 -44,37 3,12 -22.660 28.413
2022-10-04 2022-09-30 4 DNA Ginkgo Bioworks Holdings, Inc.
Class A Common Stock
M - Exercise 16.361 16.361
2022-03-14 2022-03-11 4 DNA Ginkgo Bioworks Holdings, Inc.
Class B Common Stock
A - Award 500.000 3.181.757 18,64
2022-03-14 2022-03-10 4 DNA Ginkgo Bioworks Holdings, Inc.
Class B Common Stock
F - Taxes -289.898 2.641.757 -9,89 3,37 -976.956 8.902.721
2022-03-14 2022-03-10 4 DNA Ginkgo Bioworks Holdings, Inc.
Class B Common Stock
A - Award 2.617.558 2.931.655 833,36
2022-01-26 2022-01-24 4 DNA Ginkgo Bioworks Holdings, Inc.
Restricted Stock Units
A - Award 40.000 40.000
2021-09-20 2021-09-16 4 DNA Ginkgo Bioworks Holdings, Inc.
Class B Common Stock
A - Award 314.097 314.097
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)